Best Practice

Sergiu’s Journey Back to Life

March 11, 2025

For three years, Sergiu’s life was dominated by extreme high blood pressure – an invisible yet life-threatening burden. Medications management was not enough, and daily life became a struggle. But then came the turning point: a renal denervation treatment changed everything. Today, Sergiu can be there for his family again, play sports, work, and fully enjoy life. Watch his inspiring story and discover how modern treatment can bring hope.

“Going for treatment with the Paradise™ Ultrasound RDN procedure was a great decision for me because now I have my blood pressure under control again. Prior to it, it was all over the board, I was taking all those medications, and my blood pressure did not drop. For me personally, it is like a rebirth.”

Sergiu, 42 years old

Back to Overview

Privacy Statement | Terms & Conditions | Corporate Governance | Patents | Connect

The PARADISE™ system is FDA approved for sale in the United States and is CE marked and approved for sale in markets where the CE mark is accepted.

© 2025 Recor Medical, Inc. All rights reserved. The PARADISE™ system is FDA approved for sale in the United States and is CE marked and approved for sale in markets where the CE mark is accepted, per approved indications for use. For investigational use only in Japan. RECOR MEDICAL, PARADISE, HYDROCOOLING, SONOWAVE 360, RADIANCE, the GPS logo, and the Swirl logo are registered trademarks in the EU and the other countries, RECOR and the RADIANCE logo are also trademarks of Recor Medical, Inc. EMEA 03/2025

Important Safety Information
Prescription Only. Brief Summary – Prior to use, please reference the Instructions for Use

Indications for Use
The Paradise™ Ultrasound Renal Denervation System (Paradise™ System) is indicated to reduce blood pressure as an adjunctive treatment in hypertension patients in whom lifestyle modifications and antihypertensive medications do not adequately control blood pressure.

Results may vary. The most common risks include pain, vascular site injury and vasospasm. See full important safety information: https://www.recormedical.eu/paradise-ultrasound-rdn-system/#safety

Recor Medical, headquartered in Palo Alto, California, USA, a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd. recormedical.eu is Recor Medical, Otsuka Medical Devices Europe GmbH website (the Site). We control and operate this Site from Europe. This Site is intended for use by European residents only and contains information regarding the Paradise™ System, which is approved for sale in the EU and bears a CE mark.

Recor Medical Europe GmbH
Europa-Allee 52 · 60327 Frankfurt · Germany
Amtsgericht Frankfurt am Main: HRB 123214
Chief Executive Officers: Lara Barghout, Michael Jones, Ronan O`Connor